Rocio Garcia Carbonero, MD
Hospital 12 de Octubre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rocio Garcia Carbonero, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:08 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT01971281 · Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)NovoCure Ltd. · unknown · Pancreatic Adenocarcinoma · study director
- Ph2/Ph3NCT01744249 · Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine CarcinomasGrupo Espanol de Tumores Neuroendocrinos · completed · Neuroendocrine Tumors, Advanced Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.